Browse 1,662 uterine cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.
Endometrial cancer, which starts in the lining of the uterus, is the most common gynecologic cancer in the United States and one of the few cancers whose death rate has been rising. The most common early warning sign is bleeding after menopause, which is why it is often found early and treated with surgery. Research matters most for cancer that returns or has spread, where immunotherapy combined with chemotherapy became a standard first treatment only in the past few years, and trials are testing new targeted drugs matched to the tumor's genetic profile.
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Fairfax VA, Grand Rapids MI, Irving TX, Austin TX,
Sponsor: Vividion Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06804824
Phase 1, Recruiting
Feasibility of Remote Activity Assessment and PRO Collection Among Transgender Cancer Survivors
for
Neoplasms, Chronic Disease
Location: Los Angeles CA
Sponsor: Cedars-Sinai Medical Center
Sex: All
Age: 18+
Code: NCT05391217
Recruiting
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
for
Neoplasms, Solid Tumors
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT03366116
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Radiotherapy Patient Education With Virtual Reality
for
Anxiety, Cancer
Location: Miami FL
Sponsor: University of Miami
Sex: All
Age: 18+
Code: NCT06506435
Recruiting
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
for
Breast Cancer, Solid Tumors, Adult
Location: Boston MA, New York NY, Fairfax VA, Tampa FL,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT05768139
Phase 1, Phase 2, Recruiting
Personalized Models for Cancer Research
for
Solid Tumor, Adult
Location: New York NY
Sponsor: New York Stem Cell Foundation Research Institute
Sex: All
Age: 18+
Code: NCT06350539
Recruiting
Communication About Sexual Health in Gynecologic Cancer
for
Gynecologic Cancers
Location: Philadelphia PA
Sponsor: Fox Chase Cancer Center
Sex: Female
Age: 18+
Code: NCT06904339
Recruiting
IMmunotherapy: Prospective Assessment of Cannabis Treatment in Cancer
for
Cancer
Location: Philadelphia PA
Sponsor: State University of New York at Buffalo
Sex: All
Age: 18+
Code: NCT06206941
Recruiting
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
for
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC),
Location: Boston MA, New Haven CT, New York NY, Baltimore MD,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT06040541
Phase 1, Recruiting
Dose-Escalation and Dose-Expansion Study of ZX-4081 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Huntersville NC
Sponsor: Nanjing Zenshine Pharmaceuticals
Sex: All
Age: 18+
Code: NCT05118841
Phase 1, Recruiting
Finding the Cause for Post-Transplant Diabetes Mellitus After Allogeneic Hematopoietic Cell Transplant
for
Diabetes Mellitus, Cancer
Location: Nashville TN
Sponsor: Vanderbilt-Ingram Cancer Center
Sex: All
Age: 18 - 70+
Code: NCT03415139
Recruiting
To Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetic Profile of ABN401 in Patients With Advanced Solid Tumors Harboring c-MET Dysregulation
for
Advanced Solid Tumors
Location: Orange City FL, Lake City FL, Houston TX
Sponsor: Abion Inc
Sex: All
Age: 18+
Code: NCT05541822
Phase 2, Recruiting
Heuristic Tool To Improve Symptom Self-Management in Adolescents and Young Adults With Cancer
for
Symptoms and Signs, Cancer, Childhood Cancer
Location: Richmond VA, Kansas City MO, Salt Lake City UT
Sponsor: Virginia Commonwealth University
Sex: All
Age: 15 - 29
Code: NCT05958316
Recruiting
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
for
Advanced Solid Tumor
Location: Boston MA, Fairfax VA, Plantation FL, Tamarac FL,
Sponsor: DualityBio Inc.
Sex: All
Age: 18+
Code: NCT05785741
Phase 1, Phase 2, Recruiting
FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations
for
Solid Tumor, MET Alteration
Location: Washington D.C. DC, Canton OH, Nashville TN
Sponsor: Pierre Fabre Medicament
Sex: All
Age: 18+
Code: NCT06669117
Phase 1, Phase 2, Recruiting
This is a Study to Evaluate the Safety and Tolerability of ABL503, and to Determine the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) of ABL503 in Subjects with Any Progressive Locally Advanced or Metastatic Solid Tumors
for
Advanced Solid Tumor
Location: Denver CO, San Antonio TX, Duarte CA, LA CA,
Sponsor: ABL Bio, Inc.
Sex: All
Age: 18+
Code: NCT04762641
Phase 1, Recruiting
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
for
Advanced Solid Tumors
Location: New York NY, Fairfax VA, Margate FL, Plantation FL,
Sponsor: DualityBio Inc.
Sex: All
Age: 18+
Code: NCT05914116
Phase 1, Phase 2, Recruiting
Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory Failure